Capricor Therapeutics Inc (CAPR)
4.84
-0.12
(-2.42%)
USD |
NASDAQ |
Jun 18, 12:21
Capricor Therapeutics Cash from Investing (Quarterly): -9.502M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -9.502M |
| December 31, 2023 | -5.863M |
| September 30, 2023 | 7.721M |
| June 30, 2023 | 6.461M |
| March 31, 2023 | -3.212M |
| December 31, 2022 | 5.142M |
| September 30, 2022 | -4.177M |
| June 30, 2022 | -35.41M |
| March 31, 2022 | -0.6254M |
| December 31, 2021 | -0.3687M |
| September 30, 2021 | -0.4682M |
| June 30, 2021 | -0.3225M |
| March 31, 2021 | -0.0369M |
| December 31, 2020 | -0.2881M |
| September 30, 2020 | -0.152M |
| June 30, 2020 | -0.1075M |
| March 31, 2020 | 5.987M |
| December 31, 2019 | -5.987M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 2.985M |
| December 31, 2018 | 3.005M |
| September 30, 2018 | -0.1426M |
| June 30, 2018 | -0.002M |
| March 31, 2018 | 1.812M |
| Date | Value |
|---|---|
| December 31, 2017 | -2.984M |
| September 30, 2017 | -1.014M |
| June 30, 2017 | 4.979M |
| March 31, 2017 | 4.001M |
| December 31, 2016 | -10.59M |
| September 30, 2016 | -0.0146M |
| June 30, 2016 | -0.0316M |
| March 31, 2016 | 5.449M |
| December 31, 2015 | 4.993M |
| September 30, 2015 | 2.415M |
| June 30, 2015 | -0.0233M |
| March 31, 2015 | -15.52M |
| December 31, 2014 | 0.3754M |
| September 30, 2014 | -0.0711M |
| June 30, 2014 | -0.069M |
| March 31, 2014 | -0.0943M |
| December 31, 2013 | 1.276M |
| September 30, 2013 | 1.102M |
| June 30, 2013 | 0.9696M |
| March 31, 2013 | 0.431M |
| December 31, 2012 | -4.318M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | -0.002M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-35.41M
Minimum
Jun 2022
7.721M
Maximum
Sep 2023
-2.060M
Average
-0.3053M
Median
Cash from Investing (Quarterly) Benchmarks
| Cutera Inc | -0.278M |
| Inovio Pharmaceuticals Inc | 45.38M |
| Stereotaxis Inc | 0.00 |
| Vaxart Inc | -5.024M |
| Allogene Therapeutics Inc | 22.13M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.268M |
| Cash from Financing (Quarterly) | 2.290M |
| Free Cash Flow | -33.33M |
| Free Cash Flow Per Share (Quarterly) | -0.0616 |
| Free Cash Flow to Equity (Quarterly) | -1.933M |
| Free Cash Flow Yield | -24.33% |